• SENSEX 77,891.46
    -74.89 (--0.10%)
  • BANKNIFTY 57,885.85
    439.60 (+0.77%)
  • UltraTech Cem.
    11,575.00 10,329.00(%)
  • JSW Energy
    550.85 428.00(%)
  • Urban Company
    146.00 201.00(%)
  • Thyrocare Tech.
    594.30 342.55(%)
  • Fortis Health.
    901.50 1,105.00(%)
  • Godrej Consumer
    937.00 1,308.40(%)
  • Larsen & Toubro
    4,067.95 4,440.00(%)
  • Bharti Airtel
    1,970.05 2,174.70(%)
  • Netweb Technol.
    5,160.00 5,241.65(%)
  • Astral
    1,599.00 1,767.95(%)
  • ICICI Bank
    1,408.10 1,187.55(%)
  • HDFC Bank
    724.45 722.00(%)
  • Cupid
    295.00 290.00(%)
  • Reliance Industries
    1,307.10 1,250.55(%)
  • SBI
    1,073.20 798.60(%)
  • Bajaj Finserv
    2,037.00 2,194.65(%)
  • ITC
    278.20 426.50(%)
  • Lenskart Solut.
    627.35 595.70(%)
  • Hindustan Copper
    570.00 759.20(%)
  • Prudent Corp.
    3,280.00 1,955.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

NGL Fine Chem Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 4558.0
  • ISIN : INE887E01022
3,409.00 -39 (-1.12%)
  • As on 13 Aug 2026 (EOD)

  • Today’s Low

    3,380.00

  • Today’s High

    3,602.00

  • Open

    3,427.10

  • Perv Close

    3,447.70

  • 52W Low

    1,216.20

  • 52W High

    3,602.00

Key Indicators

  • P/E(TTM)

    45.13

  • Mar.Cap (₹Cr.)

    2,106.76

  • Div & Yield %

    0.05

  • Book Value(₹)

    517.70

  • Debt-Equity Ratio

    -1.12

  • AGM Date

    12-Aug-2026

  • EPS

    75.60

  • P/E Ratio

    45.13

Financials Ratios

  • Debt-Equity Ratio

    0.14

  • Mar.Cap (₹Cr.)

    2,106.76

  • RONW (%)

    17.03

  • ROCE (%)

    20.16

Score Board

  • Equity (₹ in Cr.)

    3.09

  • BV (₹)

    517.70

  • Sales( ₹ in Cr.)

    488.77

  • NP (in Cr.)

    46.72

  • NP Var(%)

    155.0

  • Div%

    35.0

  • CPS (₹)

    102.00

  • EPS (₹)

    75.60

  • Traded Value (₹ in Lakhs)

    2,108.52

  • 52 Week High

    3,602.00

  • 52 Week Low

    1,216.20

  • Price BSE

    3412.0

  • Price NSE

    3,409.00

  • Market Capital( in Cr.)

    2,108.52

  • P/C Ratio

    33.50

  • P/E Ratio

    45.10

  • Price Vs.BV

    75.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 488.77 359.29 328.97 275.05 318.67 258.18
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 488.77 359.29 328.97 275.05 318.67 258.18
Other Income 14.85 9.76 15.90 7.61 12.64 8.55
Stock Adjustments 8.39 -1.36 12.06 -23.29 22.03 -1.86
Total Income 512.01 367.69 356.93 259.37 353.34 264.87
EXPENDITURE :            
Raw Materials 252.64 186.20 169.05 118.84 172.92 102.77
Power and Fuel Cost 25.06 20.48 18.60 15.45 14.47 9.27
Employee Cost 60.25 50.71 41.32 34.25 33.05 27.24
Other Manufacturing Expenses 68.64 53.17 47.44 37.17 41.21 26.49
Selling and Administration Expenses 18.45 15.33 14.51 11.24 8.56 11.52
Miscellaneous Expenses 11.03 5.47 5.34 6.09 4.57 1.98
Employee Benefit Expenses 60.25 50.71 41.32 34.25 33.05 27.24
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 436.07 331.37 296.27 223.05 274.77 179.27
Operating Profit 75.95 36.33 60.66 36.33 78.56 85.59
Interest 5.03 3.18 1.80 1.83 1.91 2.20
Gross Profit 70.92 33.15 58.86 34.50 76.65 83.39
Depreciation 16.30 9.27 8.15 7.90 7.67 7.39
Profit Before Tax 54.62 23.88 50.71 26.60 68.98 76.00
Current Tax 13.66 5.34 11.41 7.21 17.15 19.07
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.67 0.41 0.78 -0.73 -0.42 1.46
Reported Net Profit 41.63 18.13 38.52 20.12 52.25 55.47
Extraordinary Items -5.09 -0.17 0.00 0.00 0.00 0.00
Adjusted Net Profit 46.72 18.30 38.52 20.12 52.25 55.47
Adjustment below Net Profit -0.23 -0.24 -0.15 -0.08 -0.05 -0.14
P & L Balance brought forward 274.31 257.51 220.22 201.27 150.15 95.91
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.08 1.08 1.08 1.08 1.08 1.08
P & L Balance carried down 314.64 274.31 257.51 220.22 201.27 150.15
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 35.00 35.00 35.00 35.00 35.00 35.00
Dividend Per Share(Rs) 1.75 1.75 1.75 1.75 1.75 1.75
Earnings Per Share-Unit Curr 67.39 29.35 62.35 32.57 84.57 89.79
Earnings Per Share(Adj)-Unit Curr 67.39 29.35 62.35 32.57 84.57 89.79
Book Value 517.86 452.60 425.39 365.04 334.36 251.62
Book Value(Adj)-Unit Curr 517.86 452.60 425.39 365.04 334.36 251.62

Shareholding Pattern

  • Promoter Group

    72.49%

  • Public Share Holding

    27.51%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 517,871 8.38 517,871 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,960,775 64.11 3,960,775 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,478,646 72.49 4,478,646 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 2,993 0.05 2,993 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,527 0.02 1,527 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 4,520 0.07 4,520 4
2] Non Institution
Bodies Corporate 103,356 1.67 94,856 83
Clearing Members 13,784 0.22 13,784 12
Directors of their Relatives 7,950 0.13 7,950 3
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 43,823 0.71 43,823 383
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 112,568 1.82 112,568 286
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 0 0.00 0 0
Individuals holding nominal share capital up to Rs. 1 lakh 1,397,867 22.63 1,214,320 12,602
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,000 0.02 1,000 2
Others 0 0.00 0 0
Sub Total 1,694,858 27.43 1,502,511 13,384
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 6,178,024 100.00 5,985,677 13,393

Company Background

NGL Fine Chem LtdPharmaceuticals - Indian - Bulk Drugs

  • NGL Fine Chem Ltd
  • BSE Code : 4558.0
  • ISIN : INE887E01022

  • Incorporation Year

    1981

  • Registered Office

    301 E Square Subhash Road
    Vile Parle (East), Mumbai,
    Maharashtra-400057

  • Telephone

    +91-22-2663 6450

  • FAX

  • Chairman

    Dhananjay N Mungale

  • Managing Director

  • Company Secretary

    Shivam Gharat

  • Auditor

    Manek & Associates

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    Purva Sharegistry (India) Pvt
    Shiv Shakti Indust,
    Unit No 9 Lower Pare,7 B J R Boricha Marg
    Mumbai - Mumbai-400011

NGL Fine Chem Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
NGL Fine Chem 3,411.85 503.63 488.77 50.64 16.42
Abbott India 28,146.90 7,217.19 6,929.05 38.54 43.78
Astrazeneca Phar 7,905.70 2,304.07 2,275.58 116.52 27.86
P & G Health Ltd 5,953.30 944.52 934.17 27.69 71.75
Glaxosmi. Pharma 2,619.65 3,932.76 3,790.20 41.85 58.17
Cipla 1,461.55 20,102.60 18,979.95 38.41 13.88
Bliss GVS Pharma 488.20 773.53 729.81 53.53 12.51
Amrutanjan Healt 487.20 469.50 451.82 24.32 21.89
Fermenta Biotec. 473.40 474.15 450.25 21.68 18.77
Guj. Themis Bio. 352.85 152.47 150.80 78.94 27.21
Ambalal Sarabhai 44.93 19.52 3.94 31.42 6.77